Targeting Skeletal Muscle Oxidative Metabolism to Treat Human Disease
First ever international conference from the world's leading experts on skeletal muscle oxidative metabolism
This Symposium has taken place for 2016.
£75 Student rate
£150 Individual rate (non student)
£400 Industry rate
Margaret Turner Warwick Education Centre
Imperial College London
Royal Brompton Campus
London SW3 6LY
This is the first international symposium dedicated to this topic: mitochondrial oxidative capacity and fibre-type plasticity of skeletal muscle, emphasising the relevance to human diseases such as type 2 diabetes and Chronic Obstructive Pulmonary Disease (COPD). It brings together international experts, who would otherwise not be seen collectively at any other conference, to present their newest data. The symposium is aimed at researchers working on skeletal muscle metabolism as well as those studying diseases where targeting muscle metabolism will be of benefit by improving metabolic control (e.g type 2 diabetes) and exercise capacity (e.g. COPD and cardiac failure), for whom this symposium offers a unique opportunity to hear, meet, share ideas and develop collaborations with the world experts and one another.
There is a chance for researchers to present work in the form of posters. Time will be allocated for poster viewing throughout the day and the conference will conclude with a dedicated poster session. The deadline for abstract submission is 26th September 2016. Full information is provided upon registration.
To gain understanding of:
1. Emerging molecular mechanisms regulating skeletal muscle fibre type plasticity in adult muscle and fibre type-specification during development
2. The clinical relevance of impaired skeletal muscle oxidative metabolism to human diseases such as type 2 diabetes and Chronic Obstructive Pulmonary Disease
3. The influence of exercise on skeletal muscle oxidative metabolism in humans
4. Key topics for future research to advance the field
Clinical and non-clinical researchers (including industry) interested in skeletal muscle metabolism, effects of exercise on skeletal muscle metabolism, effects of muscle metabolism on type 2 diabetes, obesity and exercise limitation in chronic diseases.
- Prof Stefano Schiaffino, Vice President, Venetian Institute of Molecular Medicine (VIMM) University of Padova
- Dr David Glass, Executive Director, Novartis Institutes for Biomedical Research, Harvard Medical School
- Prof Marco Sandri, University of Padova
- Prof Anna Krook, Joint Leader of Integrative Physiology Department, Karolinska Institutet
- Prof Bill Evans President Muscle and Health, Kinemed Inc. and Adjunct Professor of Medicine, Duke University, North Carolina
- Prof Rhonda Bassel-Duby, UT Southwestern
- Prof Mike Polkey Royal Brompton Hospital and Imperial College London